Opportunity Information: Apply for RFA AG 21 035
This funding opportunity, titled "Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium Coordinating Center (U24 Clinical Trial Not Allowed)" (RFA-AG-21-035), is a National Institutes of Health (NIH) cooperative agreement intended to quickly stand up a dedicated coordinating center for a COVID-19-focused research consortium. The core aim is not to run clinical trials, but to strengthen and organize the national research response in the social, behavioral, and economic domains by providing shared infrastructure. In practice, the coordinating center would function as the backbone for consortium-wide activities, helping researchers work in a more aligned, efficient, and standardized way during the public health emergency and its aftermath.
The coordinating center is expected to support and develop multiple cross-cutting functions that improve the quality, reach, and usefulness of COVID-19-related social, behavioral, and economic research. These functions include facilitating research coordination across participating projects, supporting dissemination of findings to relevant audiences, and enabling robust data sharing activities. In other words, the center is meant to make it easier for investigators and institutions to harmonize measures, share datasets and documentation, coordinate analyses where appropriate, and push results out to decision-makers, practitioners, and communities in forms that can actually be used. Because this is a cooperative agreement (U24), NIH would likely have substantial programmatic involvement, meaning the awardee should be prepared for ongoing collaboration with NIH staff and for meeting consortium-level milestones and expectations.
Eligibility is broad and spans many types of U.S.-based organizations. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public housing authorities/Indian housing authorities; public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations (both 501(c)(3) and non-501(c)(3)); for-profit organizations (other than small businesses); and small businesses. The opportunity also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, U.S. territories or possessions, eligible federal agencies, and Indian/Native American Tribal Governments (other than federally recognized). At the same time, there are clear restrictions related to foreign involvement: non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as NIH defines them in the NIH Grants Policy Statement) are not allowed.
From an administrative standpoint, the opportunity is categorized as discretionary funding and uses the cooperative agreement instrument. It falls under the health activity category and is associated with CFDA numbers 93.313 and 93.866. The listing indicates an award ceiling of $500,000. The original closing date was June 9, 2021, and the posting was created on April 8, 2021. Overall, the grant is geared toward building and operating a centralized coordinating hub that accelerates and improves collaborative social, behavioral, and economic research on COVID-19 through coordination, dissemination support, and data-sharing infrastructure, while keeping the work fully domestic with no foreign components.Apply for RFA AG 21 035
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium Coordinating Center (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.313, 93.866.
- This funding opportunity was created on 2021-04-08.
- Applicants must submit their applications by 2021-06-09. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title and opportunity number for this funding opportunity?
The opportunity is titled "Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium Coordinating Center (U24 Clinical Trial Not Allowed)" and the opportunity number is RFA-AG-21-035.
What is the main purpose of this award?
The purpose is to rapidly stand up and operate a dedicated coordinating center that serves as shared infrastructure for a COVID-19-focused research consortium. The center is intended to strengthen and organize the national research response in social, behavioral, and economic domains by aligning participating projects and enabling efficient, standardized collaboration.
Is this award meant to fund clinical trials?
No. The opportunity explicitly states "Clinical Trial Not Allowed." The core aim is to provide consortium-wide coordinating infrastructure rather than to run clinical trials.
What type of NIH funding mechanism is being used?
This is an NIH cooperative agreement using the U24 activity code. In a cooperative agreement, NIH typically has substantial programmatic involvement, so the awardee should be prepared for ongoing collaboration with NIH staff and for meeting consortium-level milestones and expectations.
What does it mean that this is a coordinating center?
In this context, a coordinating center functions as the backbone for consortium-wide activities. It supports researchers and institutions in working in a more aligned, efficient, and standardized way by providing shared coordination, dissemination support, and data-sharing infrastructure.
What kinds of activities is the coordinating center expected to support?
The coordinating center is expected to develop and support cross-cutting functions that improve the quality, reach, and usefulness of COVID-19-related social, behavioral, and economic research. Examples described in the opportunity include facilitating coordination across participating projects, supporting dissemination of findings to relevant audiences, and enabling robust data sharing activities.
What does "research coordination" include for this consortium?
Based on the description, coordination can include helping participating projects harmonize measures, coordinate analyses where appropriate, and align consortium activities so work is carried out in a more standardized and efficient way during the public health emergency and its aftermath.
What is meant by "dissemination of findings" in this opportunity?
Dissemination support refers to helping ensure findings are communicated to relevant audiences, including decision-makers, practitioners, and communities, in forms that can be used.
What is expected regarding data sharing?
The center is expected to enable robust data sharing activities, including supporting the sharing of datasets and related documentation and making it easier for investigators and institutions to share information across the consortium.
Is NIH likely to be involved after an award is made?
Yes. Because this is a cooperative agreement (U24), the opportunity indicates NIH would likely have substantial programmatic involvement. Awardees should plan for ongoing collaboration with NIH staff and for meeting consortium-level milestones and expectations.
Who is eligible to apply?
Eligibility is broad and includes many types of U.S.-based organizations. Eligible applicants include:
- State, county, and local governments
- Special district governments
- Independent school districts
- Public housing authorities/Indian housing authorities
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Nonprofit organizations (501(c)(3) and non-501(c)(3))
- For-profit organizations (other than small businesses)
- Small businesses
Are any additional applicant categories specifically highlighted as eligible?
Yes. The opportunity explicitly highlights additional eligible categories, including:
- Alaska Native and Native Hawaiian Serving Institutions
- Asian American Native American Pacific Islander Serving Institutions (AANAPISI)
- Hispanic-serving Institutions
- Historically Black Colleges and Universities (HBCUs)
- Tribally Controlled Colleges and Universities (TCCUs)
- Faith-based or community-based organizations
- Regional organizations
- U.S. territories or possessions
- Eligible federal agencies
- Indian/Native American Tribal Governments (other than federally recognized)
Are foreign organizations eligible to apply?
No. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply.
Can a U.S. organization apply if the work includes a non-U.S. component?
No. The opportunity states that non-domestic components of U.S. organizations are not eligible.
Are foreign components allowed in any form?
No. Foreign components (as NIH defines them in the NIH Grants Policy Statement) are not allowed.
What is the award ceiling for this opportunity?
The listing indicates an award ceiling of $500,000.
What is the funding category and instrument type?
The opportunity is categorized as discretionary funding and uses a cooperative agreement instrument.
What activity category is associated with this funding?
It falls under the health activity category.
Which CFDA numbers are associated with this opportunity?
The opportunity is associated with CFDA numbers 93.313 and 93.866.
When was the opportunity posted and when did it close?
The posting was created on April 8, 2021. The original closing date was June 9, 2021.
What is the overall outcome this coordinating center is meant to support?
The overall goal is to accelerate and improve collaborative social, behavioral, and economic research on COVID-19 by building and operating a centralized hub that strengthens coordination, supports dissemination, and enables data sharing, while keeping the work fully domestic with no foreign components.
Browse more opportunities from the same category: Health
Next opportunity: BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
Previous opportunity: NIST Standards Services Curricula Development Cooperative Agreement Program (SSCD CAP)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 21 035
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 21 035) also looked into and applied for these:
| Funding Opportunity |
|---|
| National Institute of General Medical Sciences (NIGMS) Bridges to the Doctorate (T32) Apply for PAR 21 198 Funding Number: PAR 21 198 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed) Apply for PAR 21 159 Funding Number: PAR 21 159 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Osra (Family) Activity Apply for RFI 263 21 00002 Funding Number: RFI 263 21 00002 Agency: Egypt USAID-Cairo Category: Health Funding Amount: Case Dependent |
| Centers for Multiple Chronic Diseases Associated with Health Disparities: Prevention, Treatment, and Management (P50 Clinical Trial Required) Apply for RFA MD 21 007 Funding Number: RFA MD 21 007 Agency: National Institutes of Health Category: Health Funding Amount: $3,000,000 |
| Enhancing NIDCD's Extramural Workforce Diversity through Research Experiences (R25 Clinical Trial Not Allowed) Apply for PAR 21 186 Funding Number: PAR 21 186 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Identification of Positive Valence System Related Targets for Novel Suicide Prevention Approaches (R21 Clinical Trial Optional) Apply for PAS 21 215 Funding Number: PAS 21 215 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Black Children and Adolescents (R01 Clinical Trial Optional) Apply for RFA MH 21 185 Funding Number: RFA MH 21 185 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R01 Clinical Trial Optional) Apply for RFA MH 21 187 Funding Number: RFA MH 21 187 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R34 Clinical Trial Optional) Apply for RFA MH 21 188 Funding Number: RFA MH 21 188 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Social and Behavior Change (SBC) Research Apply for 7200AA21APS00008 Funding Number: 7200AA21APS00008 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| Identification of Positive Valence System Related Targets for Novel Suicide Prevention Approaches (R01 - Clinical Trial Optional) Apply for PAS 21 216 Funding Number: PAS 21 216 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Black Children and Adolescents (R34 Clinical Trial Optional) Apply for RFA MH 21 186 Funding Number: RFA MH 21 186 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Centers for HIV Structural Biology (U54 Clinical Trial Not Allowed) Apply for RFA AI 21 030 Funding Number: RFA AI 21 030 Agency: National Institutes of Health Category: Health Funding Amount: $3,500,000 |
| NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed) Apply for PAR 21 234 Funding Number: PAR 21 234 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Systems Approach to Understand Mechanisms of Heterogeneous Response to Influenza (R01 Clinical Trial Not Allowed) Apply for RFA AI 21 017 Funding Number: RFA AI 21 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Resource Center for the Support for Research Excellence (SuRE) Program (U24 - Clinical Trial Not Allowed) Apply for PAR 21 227 Funding Number: PAR 21 227 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Translational Neural Devices (U44 Clinical Trial Optional) Apply for RFA NS 21 022 Funding Number: RFA NS 21 022 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Translational Neural Devices (UG3/UH3 - Clinical Trial Optional) Apply for RFA NS 21 021 Funding Number: RFA NS 21 021 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Addressing Social Determinants of Health to Eliminate Oral Health Disparities (UG3/UH3 Clinical Trials Optional) Apply for RFA DE 22 002 Funding Number: RFA DE 22 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed) Apply for PAR 21 225 Funding Number: PAR 21 225 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 21 035", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.